BSP - Biological Signal Processing

Noninvasive Diagnosis of Cardiac Disease

Health Tech & Life Sciences
Non Active, May 2018
Mature Tel Aviv-Yafo Founded 2000
LinkedIn
Total raised
Stage
Mature
Founded
2000
Headcount
3
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

BSP - Biological Signal Processing offers products for the noninvasive diagnosis and monitoring of ischemic heart disease. The companys HyperQ line of products, which arebased on patented high-frequency technology, offers solutions for both stress ECG tests and resting ECG tests. The HyperQ Stress offers a significant improvement in the diagnosis of patients suspected of having coronary artery disease. The HyperQ Rest provides a tool to enable emergency department teams to detectacute coronary syndrome. Numerous trials and clinical studies conducted with thousands of patients in Israel, Europe, Asia, and the United Stateshave confirmed the significantly enhanced diagnostic value of the HyperQ technology for the detection of ischemia.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics Devices
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

ecgnon-invasivemonitoringheart-diseasesmedical-devicescardiovascularcardiologydiagnosticsclinicsclinical-datahealthcare-providershospitals